Press "Enter" to skip to content

New patent expiration for Novo Nordisk drug NORDITROPIN NORDIFLEX

0

Annual Drug Patent Expirations for NORDITROPIN+NORDIFLEX
Annual Drug Patent Expirations for NORDITROPIN+NORDIFLEX

Norditropin Nordiflex is a drug marketed by Novo Nordisk Inc
and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug.

This drug has eigthy-four patent family members in twenty-three countries.

The generic ingredient in NORDITROPIN NORDIFLEX is somatropin recombinant. Two suppliers are listed for this compound. Additional details are available on the somatropin recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

    Do NOT follow this link or you will be banned from the site!